Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

Part of paid clinical trials in Rochester, New York.

Sponsor
University of Rochester
Study ID
NCT06295588
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Fatigue
  • Inflammation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Fucoidan extracted from F. Vesiculosus — DRUG
    4 g daily
  • Fucoidan extracted from U. Pinnatifida — DRUG
    4 g daily

Study Details

To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation.

Key Dates

Start date
Jul 26, 2025
Status verified
Nov 2025
Primary completion
Dec 31, 2026
Completion
Jun 1, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Fucoidan
    They will receive 4 grams daily of fucoidan extracted from F. Vesiculosus for 8 weeks.
  • Active Comparator: Usual Care
    They will receive usual care for 8 weeks followed by 4 grams daily of fucoidan extracted from U. Pinnatifida for 8 weeks.

Primary Outcome Measure

percentage of participants who are randomized to the study out of all participants approached [ Time Frame: 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Rochester Medical CenterRochesterNew York14642
Jeremy McGuire, PhD
[email protected]
5852740472
Jeremy McGuire
Jeremy McGuire, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, NY

By research site
University of Rochester Medical Center· Rochester, NY

Related Studies